CareRx Corporation
TSX:CRRX.TOMedical - Care Facilities
+$0.02 today
- Market cap
- $203.06M
- Beta
- 0.62
- P/E (TTM)
- 7.4
- EPS (TTM)
- $0.43
- Dividend yield
- 1.88%
Volume 0.01M
Average 0.04M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
CareRx Corporation
TSX:CRRX.TO
Intrinsic Alpha fair value
Locked
Current Price
$3.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | -20.0% (3yr)3 analysts |
| Revenue | N/A | N/A | -1.0% | +4.2% (3yr)4 analysts |
| Net Income | N/A | N/A | N/A | -20.5% (3yr)4 analysts |
| EBIT | N/A | N/A | N/A | +27.8% (3yr)4 analysts |
Analysis
Recent growth has been strongest in Revenue at -1.0% over three years. Forward estimates point to EBIT at +27.8% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Profound Medical Corp. TSX:PRN.TO | $388.24M | $10.60 | Not rated | -6.3 | +16.06% |
Auxly Cannabis Group Inc. TSX:XLY.TO | $365.45M | $3.54 | Overvalued | 7.3 | +2334.48% |
Medical Facilities Corporation TSX:DR.TO | $274.81M | $16.95 | Undervalued | 8.7 | +22.92% |
HLS Therapeutics Inc. TSX:HLS.TO | $114.77M | $3.71 | Undervalued | -9.6 | -24.65% |
Helix BioPharma Corp. TSX:HBP.TO | $64.92M | $0.85 | Not rated | -32.6 | -64.90% |
Continue the stock analysis
Jump to another research area for this company.